Home
All Companies
Companies in A
Abbott Laboratories
Europe Diabetes Care Devices Investment Opportunities, Analysis and Projections to 2015

Pathology

Summary

Table of Contents

Europe Diabetes Care Devices Investment Opportunities, Analysis and Projections to 2015

Publication date: June 2009

Keywords : diabete, Insulin

Search ReportLinker

The Largest Collection of Market Research Reports

» 1.2 Million Industry Reports
» 450,000 Company Profiles

» 850,000 Market Briefings
» 40,000 Country Guides

From +200,000 authoritative sources

It also offers detailed and comprehensive coverage of industry revenue, volume, distribution and industry player share information; and the latest news, financial deals and new product development information of each of the key sub-segments of the diabetes care devices industry in Europe

Report Coverage

- The report provides diabetes care devices information broken down into detailed categories in Europe.
- Total revenues, products sold and end users.
- Industry shares of all the competitive landscape .
- Key new product development that are set to shape the industry , broken down by segment .
- Information on the top medical equipment industry players in the segment in the country covering business description, strategic analysis, and financial information.
- Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
- Product and brand updates, strategy changes, Research and Development projects , corporate growths and contractions and regulation modifications .
- Key M&A deals , partnerships, private equity investments and IPOs.
- Customer, hospitals and physicians data.

Why Should You Get This Report?

- Gain a strong understanding of the diabetes care devices industry in Europe.
- Evaluate and compare the attractiveness of the industry in the region.
- Identify growth sectors and opportunities in each market segment within the region.
- Evaluate the pipeline of key products that will change the segment , and identify threats and opportunities before the products are launched in the region.
- Analyze the competitiveness of the industry in the region and identify hotspots.
- Develop strategies based on the latest product, brand, expansion and research and development news in the region.
- Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the industry in the region.
- Identify and analyze the strengths and weaknesses of the market incumbents in the region.

Pathology Industry in Germany

1 Table of Contents
2

List of tables
8

List of figures
12

II Introduction 15
II. 1 What Is This Report About? 15

III Definitions of March kets Covered in the Report 16
III. 1 Diabetic Care Devices 16
III. 2 Glucose Monitoring Devices 16
III. 3 Insulin Delivery 16

IV Diabetes Care Devices in Europe 17
IV. 1 Diabetes Care Devices, Europe, Overall Sales ($ mn), from 2000 to 2015 17
IV. 2 Diabetes Care Devices, Europe, Segment Volume (Units), from 2000 to 2015 21
IV. 3 Diabetes Care Devices, Europe, Firms share (2007-2008) 24

V Diabetes Care Devices In Germany 25
V. 1 Diabetes Care Devices, Germany, Overall Sales ($ mn), from 2000 to 2015 25
V. 2 Diabetes Care Devices, Germany, Segment Volume (Units), from 2000 to 2015 28
V. 3 Diabetes Care Devices, Germany, Distribution Channel (2007-2008) 31
V. 3.1 Glucose Monitoring Distribution Channel (2007-2008) 31
V. 3.2 Insulin Delivery Distribution Channel (2007-2008) 31
V. 4 Diabetes Care Devices, Germany, Market Shares (2007-2008) 32
V. 4.1 Diabetes Care Devices, Germany, Market Shares (2007-2008) 32
V. 4.2 Glucose Monitoring, Germany, Market Shares (2007-2008) 33
V. 4.3 Insulin Delivery, Germany, Market Shares (2007-2008) 34

VI Diabetes Care Devices In Italy 35
VI. 1 Diabetes Care Devices, Italy, Overall Sales ($ mn), from 2000 to 2015 35
VI. 2 Diabetes Care Devices, Italy, Segment Volume (Units), from 2000 to 2015 39
VI. 3 Diabetes Care Devices, Italy, Distribution Channel (2007-2008) 42
VI. 3.1 Glucose Monitoring Distribution Channel (2007-2008) 42
VI. 3.2 Insulin Delivery Distribution Channel (2007-2008) 42
VI. 4 Diabetes Care Devices, Italy, Market Shares (2007-2008) 43
VI. 4.1 Diabetes Care Devices, Italy, Market Shares (2007-2008) 43
VI. 4.2 Glucose Monitoring, Italy, Market Shares (2007-2008) 44
VI. 4.3 Insulin Delivery, Italy, Market Shares (2007-2008) 45

VII Diabetes Care Devices In France 46
VII. 1 Diabetes Care Devices, France, Overall Sales ($ mn), from 2000 to 2015 46
VII. 2 Diabetes Care Devices, France, Segment Volume (Units), from 2000 to 2015 49
VII. 3 Diabetes Care Devices, France, Distribution Channel (2007-2008) 52
VII. 3.1 Glucose Monitoring Distribution Channel (2007-2008) 52
VII. 3.2 Insulin Delivery Distribution Channel (2007-2008) 52
VII. 4 Diabetes Care Devices, France, Market Shares (2007-2008) 53
VII. 4.1 Diabetes Care Devices, France, Market Shares (2007-2008) 53
VII. 4.2 Glucose Monitoring, France, Market Shares (2007-2008) 54
VII. 4.3 Insulin Delivery, France, Market Shares (2007-2008) 55

VIII Diabetes Care Devices In United Kingdom 56
VIII. 1 Diabetes Care Devices, United Kingdom, Overall Sales ($ mn), from 2000 to 2015 56
VIII. 2 Diabetes Care Devices, United Kingdom, Segment Volume (Units), from 2000 to 2015 59
VIII. 3 Diabetes Care Devices, United Kingdom, Distribution Channel (2007-2008) 62
VIII. 3.1 Glucose Monitoring Distribution Channel (2007-2008) 62
VIII. 3.2 Insulin Delivery Distribution Channel (2007-2008) 62
VIII. 4 Diabetes Care Devices, United Kingdom, Market Shares (2007-2008) 63
VIII. 4.1 Diabetes Care Devices, United Kingdom, Market Shares (2007-2008) 63
VIII. 4.2 Glucose Monitoring, United Kingdom, Market Shares (2007-2008) 64
VIII. 4.3 Insulin Delivery, United Kingdom, Market Shares (2007-2008) 65

IX Diabetes Care Devices In Spain 66
IX. 1 Diabetes Care Devices, Spain, Overall Sales ($ mn), from 2000 to 2015 66
IX. 2 Diabetes Care Devices, Spain, Segment Volume (Units), from 2000 to 2015 69
IX. 2.1 Diabetes Care Devices, Spain, Distribution Channel (2007-2008) 72
IX. 2.2 Glucose Monitoring Distribution Channel (2007-2008) 72
IX. 2.3 Insulin Delivery Distribution Channel (2007-2008) 72
IX. 3 Diabetes Care Devices, Spain, Market Shares (2007-2008) 73
IX. 3.1 Diabetes Care Devices, Spain, Market Shares (2007-2008) 73
IX. 3.2 Glucose Monitoring, Spain, Market Shares (2007-2008) 74
IX. 3.3 Insulin Delivery, Spain, Market Shares (2007-2008) 75

X Diabetes Care Devices In Netherlands 76
X. 1 Diabetes Care Devices, Netherlands, Overall Sales ($ mn), from 2000 to 2015 76
X. 2 Diabetes Care Devices, Netherlands, Segment Volume (Units), from 2000 to 2015 80
X. 3 Diabetes Care Devices, Netherlands, Distribution Channel (2007-2008) 83
X. 3.1 Glucose Monitoring Distribution Channel (2007-2008) 83
X. 3.2 Insulin Delivery Distribution Channel (2007-2008) 83
X. 4 Diabetes Care Devices, Netherlands, Market Shares (2007-2008) 84
X. 4.1 Diabetes Care Devices, Netherlands, Market Shares (2007-2008) 84
X. 4.2 Glucose Monitoring, Netherlands, Market Shares (2007-2008) 85
X. 4.3 Insulin Delivery, Netherlands, Market Shares (2007-2008) 86

XI Diabetes Care Devices In Belgium 87
XI. 1 Diabetes Care Devices, Belgium, Overall Sales ($ mn), from 2000 to 2015 87
XI. 2 Diabetes Care Devices, Belgium, Segment Volume (Units), from 2000 to 2015 90
XI. 3 Diabetes Care Devices, Belgium, Distribution Channel (2007-2008) 93
XI. 3.1 Glucose Monitoring Distribution Channel (2007-2008) 93
XI. 3.2 Insulin Delivery Distribution Channel (2007-2008) 93
XI. 4 Diabetes Care Devices, Belgium, Market Shares (2007-2008) 94
XI. 4.1 Diabetes Care Devices, Belgium, Market Shares (2007-2008) 94
XI. 4.2 Glucose Monitoring, Belgium, Market Shares (2007-2008) 95
XI. 4.3 Insulin Delivery, Belgium, Market Shares (2007-2008) 96

XII Overview of Key Firms in Europe Diabetes Care Devices March ket 97
XII. 1 F. Hoffmann-La Roche Ltd. 97
XII. 1.1 Company Profile 97
XII. 1.2 Value Chain Analysis 98
XII. 1.3 F. Hoffmann-La Roche Ltd Pipeline Products 100
XII. 2 Bayer HealthCare AG 101
XII. 2.1 Company Profile 101
XII. 2.2 Value Chain Analysis 102
XII. 2.3 Bayer HealthCare AG Pipeline Products 104
XII. 3 LifeScan, Inc. 105
XII. 3.1 Company Profile 105
XII. 3.2 LifeScan, Inc. Pipeline Products 105
XII. 4 Abbott Laboratories 107
XII. 4.1 Company Profile 107
XII. 4.2 Value Chain Analysis 108
XII. 4.3 Abbott Laboratories Pipeline Products 110
XII. 5 Medtronic, Inc. 112
XII. 5.1 Company Profile 112
XII. 5.2 Value Chain Analysis 113
XII. 5.3 Medtronic, Inc. Pipeline Products 115
XII. 6 November o Nordisk A/S 123
XII. 6.1 Company Profile 123
XII. 6.2 November o Nordisk A/S Pipeline Products 123
XII. 7 ARKRAY, Inc. 125
XII. 7.1 Company Profile 125
XII. 7.2 ARKRAY, Inc. Pipeline Products 125
XII. 8 Becton, Dickinson and Firms 127
XII. 8.1 Company Profile 127
XII. 8.2 Value Chain Analysis 127
XII. 9 Eli Lilly and Firms 129
XII. 9.1 Company Profile 129
XII. 9.2 Value Chain Analysis 129
XII. 9.3 Eli Lilly and Firms Pipeline Products 132
XII. 10 Terumo Corporation 133
XII. 10.1 Company Profile 133
XII. 10.2 Value Chain Analysis 133
XII. 11 Animas Corporation 136
XII. 11.1 Company Profile 136
XII. 12 Sanofi-Aventis 136
XII. 12.1 Company Profile 136
XII. 13 Smiths Medical 137
XII. 13.1 Company Profile 137
XII. 13.2 Value Chain Analysis 138
XII. 14 Apex Biotechnology Corp. 140
XII. 14.1 Company Profile 140
XII. 15 Panasonic Corporation 140
XII. 15.1 Company Profile 140
XII. 16 A. Menarini Diagnostics S.r.l. 141
XII. 16.1 Company Profile 141
XII. 16.2 A. Menarini Diagnostics S.r.l. Pipeline Products 141
XII. 17 EKF-diagnostic GmbH 143
XII. 17.1 Company Profile 143
XII. 18 Diabetes Management International BV 143
XII. 18.1 Company Profile 143

XIII Financial Deals Landscape 144
XIII. 1 Partner agreements 144
XIII. 1.1 Amylin Pharmaceuticals Plans to Enter Into an Agreement with Eli Lilly 144

XIV Appendix 145
XIV. 1 World March kets Direct Research Methodology 145
XIV. 2 Coverage 146
XIV. 3 Secondary Research 146
XIV. 4 Primary Research 147
XIV. 5 Models 147
XIV. 6 Forecasted data s 148
XIV. 7 Expert Panel Validation 148
XIV. 8 Currency Conversion 149
XIV. 9 Contact Us 150
XIV. 10 Disclaimer 150
List of tables

Data table 1: Diabetes Care Devices, Europe, Overall Sales ($ mn), from 2000 to 2015 17
Data table 2: Diabetes Care Devices, Europe, Cross-Category Analysis, from 2000 to 2015 18
Data table 3: Diabetes Care Devices, Europe, Overall Sales ($ mn), Historical data , from 2000 to 2008 19
Data table 4: Diabetes Care Devices, Europe, Overall Sales ($ mn), Forecasted data , from 2008 to 2015 20
Data table 5: Diabetes Care Devices, Europe, Segment Volume (Units), from 2000 to 2015 21
Data table 6: Diabetes Care Devices, Europe, Segment Volume (Units), Historical data , from 2000 to 2008 22
Data table 7: Diabetes Care Devices, Europe, Segment Volume (Units), Forecasted data , from 2008 to 2015 23
Data table 8: Diabetes Care Devices, Europe, Market Shares by Sales ($ mn), from 2007 to 2008 24
Data table 9: Diabetes Care Devices, Germany, Overall Sales ($ mn), from 2000 to 2015 25
Data table 10: Diabetes Care Devices, Germany, Overall Sales ($ mn), Historical data , from 2000 to 2008 26
Data table 11: Diabetes Care Devices, Germany, Overall Sales ($ mn), Forecasted data , from 2008 to 2015 27
Data table 12: Diabetes Care Devices, Germany, Segment Volume (Units), from 2000 to 2015 28
Data table 13: Diabetes Care Devices, Germany, Segment Volume (Units), Historical data , from 2000 to 2008 29
Data table 14: Diabetes Care Devices, Germany, Segment Volume (Units), Forecasted data , from 2008 to 2015 30
Data table 15: Glucose Monitoring, Germany, Distribution Channel by Sales ($mn), from 2007 to 2008 31
Data table 16: Insulin Delivery, Germany, Distribution Channel by Sales ($mn), from 2007 to 2008 31
Data table 17: Diabetes Care Devices, Germany, Market Shares by Sales ($ mn), from 2007 to 2008 32
Data table 18: Glucose Monitoring, Germany, Market Shares by Sales ($ mn), from 2007 to 2008 33
Data table 19: Insulin Delivery, Germany, Market Shares by Sales ($ mn), from 2007 to 2008 34
Data table 20: Diabetes Care Devices, Italy, Overall Sales ($ mn), from 2000 to 2015 35
Data table 21: Diabetes Care Devices, Italy, Cross-Category Analysis, from 2000 to 2015 36
Data table 22: Diabetes Care Devices, Italy, Overall Sales ($ mn), Historical data , from 2000 to 2008 37
Data table 23: Diabetes Care Devices, Italy, Overall Sales ($ mn), Forecasted data , from 2008 to 2015 38
Data table 24: Diabetes Care Devices, Italy, Segment Volume (Units), from 2000 to 2015 39
Data table 25: Diabetes Care Devices, Italy, Segment Volume (Units), Historical data , from 2000 to 2008 40
Data table 26: Diabetes Care Devices, Italy, Segment Volume (Units), Forecasted data , from 2008 to 2015 41
Data table 27: Glucose Monitoring, Italy, Distribution Channel by Sales ($mn), from 2007 to 2008 42
Data table 28: Insulin Delivery, Italy, Distribution Channel by Sales ($mn), from 2007 to 2008 42
Data table 29: Diabetes Care Devices, Italy, Market Shares by Sales ($ mn), from 2007 to 2008 43
Data table 30: Glucose Monitoring, Italy, Market Shares by Sales ($ mn), from 2007 to 2008 44
Data table 31: Insulin Delivery, Italy, Market Shares by Sales ($ mn), from 2007 to 2008 45
Data table 32: Diabetes Care Devices, France, Overall Sales ($ mn), from 2000 to 2015 46
Data table 33: Diabetes Care Devices, France, Overall Sales ($ mn), Historical data , from 2000 to 2008 47
Data table 34: Diabetes Care Devices, France, Overall Sales ($ mn), Forecasted data , from 2008 to 2015 48
Data table 35: Diabetes Care Devices, France, Segment Volume (Units), from 2000 to 2015 49
Data table 36: Diabetes Care Devices, France, Segment Volume (Units), Historical data , from 2000 to 2008 50
Data table 37: Diabetes Care Devices, France, Segment Volume (Units), Forecasted data , from 2008 to 2015 51
Data table 38: Glucose Monitoring, France, Distribution Channel by Sales ($mn), from 2007 to 2008 52
Data table 39: Insulin Delivery, France, Distribution Channel by Sales ($mn), from 2007 to 2008 52
Data table 40: Diabetes Care Devices, France, Market Shares by Sales ($ mn), from 2007 to 2008 53
Data table 41: Glucose Monitoring, France, Market Shares by Sales ($ mn), from 2007 to 2008 54
Data table 42: Insulin Delivery, France, Market Shares by Sales ($ mn), from 2007 to 2008 55
Data table 43: Diabetes Care Devices, United Kingdom, Overall Sales ($ mn), from 2000 to 2015 56
Data table 44: Diabetes Care Devices, United Kingdom, Overall Sales ($ mn), Historical data , from 2000 to 2008 57
Data table 45: Diabetes Care Devices, United Kingdom, Overall Sales ($ mn), Forecasted data , from 2008 to 2015 58
Data table 46: Diabetes Care Devices, United Kingdom, Segment Volume (Units), from 2000 to 2015 59
Data table 47: Diabetes Care Devices, United Kingdom, Segment Volume (Units), Historical data , from 2000 to 2008 60
Data table 48: Diabetes Care Devices, United Kingdom, Segment Volume (Units), Forecasted data , from 2008 to 2015 61
Data table 49: Glucose Monitoring, United Kingdom, Distribution Channel by Sales ($mn), from 2007 to 2008 62
Data table 50: Insulin Delivery, United Kingdom, Distribution Channel by Sales ($mn), from 2007 to 2008 62
Data table 51: Diabetes Care Devices, United Kingdom, Market Shares by Sales ($ mn), from 2007 to 2008 63
Data table 52: Glucose Monitoring, United Kingdom, Market Shares by Sales ($ mn), from 2007 to 2008 64
Data table 53: Insulin Delivery, United Kingdom, Market Shares by Sales ($ mn), from 2007 to 2008 65
Data table 54: Diabetes Care Devices, Spain, Overall Sales ($ mn), from 2000 to 2015 66
Data table 55: Diabetes Care Devices, Spain, Overall Sales ($ mn), Historical data , from 2000 to 2008 67
Data table 56: Diabetes Care Devices, Spain, Overall Sales ($ mn), Forecasted data , from 2008 to 2015 68
Data table 57: Diabetes Care Devices, Spain, Segment Volume (Units), from 2000 to 2015 69
Data table 58: Diabetes Care Devices, Spain, Segment Volume (Units), Historical data , from 2000 to 2008 70
Data table 59: Diabetes Care Devices, Spain, Segment Volume (Units), Forecasted data , from 2008 to 2015 71
Data table 60: Glucose Monitoring, Spain, Distribution Channel by Sales ($mn), from 2007 to 2008 72
Data table 61: Insulin Delivery, Spain, Distribution Channel by Sales ($mn), from 2007 to 2008 72
Data table 62: Diabetes Care Devices, Spain, Market Shares by Sales ($ mn), from 2007 to 2008 73
Data table 63: Glucose Monitoring, Spain, Market Shares by Sales ($ mn), from 2007 to 2008 74
Data table 64: Insulin Delivery, Spain, Market Shares by Sales ($ mn), from 2007 to 2008 75
Data table 65: Diabetes Care Devices, Netherlands, Overall Sales ($ mn), from 2000 to 2015 76
Data table 66: Diabetes Care Devices, Netherlands, Cross-Category Analysis, from 2000 to 2015 77
Data table 67: Diabetes Care Devices, Netherlands, Overall Sales ($ mn), Historical data , from 2000 to 2008 78
Data table 68: Diabetes Care Devices, Netherlands, Overall Sales ($ mn), Forecasted data , from 2008 to 2015 79
Data table 69: Diabetes Care Devices, Netherlands, Segment Volume (Units), from 2000 to 2015 80
Data table 70: Diabetes Care Devices, Netherlands, Segment Volume (Units), Historical data , from 2000 to 2008 81
Data table 71: Diabetes Care Devices, Netherlands, Segment Volume (Units), Forecasted data , from 2008 to 2015 82
Data table 72: Glucose Monitoring, Netherlands, Distribution Channel by Sales ($mn), from 2007 to 2008 83
Data table 73: Insulin Delivery, Netherlands, Distribution Channel by Sales ($mn), from 2007 to 2008 83
Data table 74: Diabetes Care Devices, Netherlands, Market Shares by Sales ($ mn), from 2007 to 2008 84
Data table 75: Glucose Monitoring, Netherlands, Market Shares by Sales ($ mn), from 2007 to 2008 85
Data table 76: Insulin Delivery, Netherlands, Market Shares by Sales ($ mn), from 2007 to 2008 86
Data table 77: Diabetes Care Devices, Belgium, Overall Sales ($ mn), from 2000 to 2015 87
Data table 78: Diabetes Care Devices, Belgium, Overall Sales ($ mn), Historical data , from 2000 to 2008 88
Data table 79: Diabetes Care Devices, Belgium, Overall Sales ($ mn), Forecasted data , from 2008 to 2015 89
Data table 80: Diabetes Care Devices, Belgium, Segment Volume (Units), from 2000 to 2015 90
Data table 81: Diabetes Care Devices, Belgium, Segment Volume (Units), Historical data , from 2000 to 2008 91
Data table 82: Diabetes Care Devices, Belgium, Segment Volume (Units), Forecasted data , from 2008 to 2015 92
Data table 83: Glucose Monitoring, Belgium, Distribution Channel by Sales ($mn), from 2007 to 2008 93
Data table 84: Insulin Delivery, Belgium, Distribution Channel by Sales ($mn), from 2007 to 2008 93
Data table 85: Diabetes Care Devices, Belgium, Market Shares by Sales ($ mn), from 2007 to 2008 94
Data table 86: Glucose Monitoring, Belgium, Market Shares by Sales ($ mn), from 2007 to 2008 95
Data table 87: Insulin Delivery, Belgium, Market Shares by Sales ($ mn), from 2007 to 2008 96
Data table 88: F. Hoffmann-La Roche Ltd Pipeline Products by Equipment Type 100
Data table 89: F. Hoffmann-La Roche Ltd Pipeline Products by Development Stage 100
Data table 90: F. Hoffmann-La Roche Ltd Pipeline Products by Therapy Area 100
Data table 91: Bayer HealthCare AG Pipeline Products by Equipment Type 104
Data table 92: Bayer HealthCare AG Pipeline Products by Development Stage 104
Data table 93: Bayer HealthCare AG Pipeline Products by Therapy Area 104
Data table 94: Bayer HealthCare AG Pipeline Products by News Summary 104
Data table 95: LifeScan, Inc. Pipeline Products by Equipment Type 105
Data table 96: LifeScan, Inc. Pipeline Products by Development Stage 105
Data table 97: LifeScan, Inc. Pipeline Products by Therapy Area 105
Data table 98: LifeScan, Inc. Pipeline Products by Clinical Trials 106
Data table 99: LifeScan, Inc. Pipeline Products by News Summary 106
Data table 100: Abbott Laboratories Pipeline Products by Equipment Type 110
Data table 101: Abbott Laboratories Pipeline Products by Development Stage 110
Data table 102: Abbott Laboratories Pipeline Products by Therapy Area 110
Data table 103: Abbott Laboratories Pipeline Products by Clinical Trials 111
Data table 104: Abbott Laboratories Pipeline Products by News Summary 111
Data table 105: Medtronic, Inc. Pipeline Products by Equipment Type 115
Data table 106: Medtronic, Inc. Pipeline Products By Development Stage 117
Data table 107: Medtronic, Inc. Pipeline Products By Therapy Area 119
Data table 108: Medtronic, Inc. Pipeline Products By Clinical Trials 121
Data table 109: Medtronic, Inc. Pipeline Products By News Summary 122
Data table 110: November o Nordisk A/S Pipeline Products by Equipment Type 123
Data table 111: November o Nordisk A/S Pipeline Products By Development Stage 123
Data table 112: November o Nordisk A/S Pipeline Products By Therapy Area 124
Data table 113: November o Nordisk A/S Pipeline Products By Clinical Trials 124
Data table 114: ARKRAY, Inc. Pipeline Products by Equipment Type 125
Data table 115: ARKRAY, Inc. Pipeline Products by Development Stage 125
Data table 116: ARKRAY, Inc. Pipeline Products by Clinical Trials 126
Data table 117: ARKRAY, Inc. Pipeline Products by News Summary 126
Data table 118: Eli Lilly and Firms Pipeline Products by Equipment Type 132
Data table 119: Eli Lilly and Firms Pipeline Products by Development Stage 132
Data table 120: Eli Lilly and Firms Pipeline Products by Therapy Area 132
Data table 121: Eli Lilly and Firms Pipeline Products by Clinical Trials 132
Data table 122: Eli Lilly and Firms Pipeline Products by News Summary 132
Data table 123: A. Menarini Diagnostics S.r.l. Pipeline Products by Equipment Type 141
Data table 124: A. Menarini Diagnostics S.r.l. Pipeline Products By Development Stage 142
Data table 125: A. Menarini Diagnostics S.r.l. Pipeline Products By Therapy Area 142
Data table 126: A. Menarini Diagnostics S.r.l. Pipeline Products By Clinical Trials 142
Data table 127: Amylin Pharmaceuticals Plans To Enter Into An Agreement With Eli Lilly 144
Data table 128: US Dollar to Local Currency, Average Exchange Rate 2008 149
List of figures

Chart 1: Diabetes Care Devices, Europe, Overall Sales ($ mn), from 2000 to 2015 17
Chart 2: Diabetes Care Devices, Europe, Cross-Category Analysis, from 2000 to 2015 18
Chart 3: Diabetes Care Devices, Europe, Overall Sales ($ mn), Historical data , from 2000 to 2008 19
Chart 4: Diabetes Care Devices, Europe, Overall Sales ($ mn), Forecasted data , from 2008 to 2015 20
Chart 5: Diabetes Care Devices, Europe, Segment Volume (Units), from 2000 to 2015 21
Chart 6: Diabetes Care Devices, Europe, Segment Volume (Units), Historical data , from 2000 to 2008 22
Chart 7: Diabetes Care Devices, Europe, Segment Volume (Units), Forecasted data , from 2008 to 2015 23
Chart 8: Diabetes Care Devices, Europe, Market Shares (%), 2008 24
Chart 9: Diabetes Care Devices, Germany, Overall Sales ($ mn), from 2000 to 2015 25
Chart 10: Diabetes Care Devices, Germany, Overall Sales ($ mn), Historical data , from 2000 to 2008 26
Chart 11: Diabetes Care Devices, Germany, Overall Sales ($ mn), Forecasted data , from 2008 to 2015 27
Chart 12: Diabetes Care Devices, Germany, Segment Volume (Units), from 2000 to 2015 28
Chart 13: Diabetes Care Devices, Germany, Segment Volume (Units), Historical data , from 2000 to 2008 29
Chart 14: Diabetes Care Devices, Germany, Segment Volume (Units), Forecasted data , from 2008 to 2015 30
Chart 15: Diabetes Care Devices, Germany, Market Shares (%), 2008 32
Chart 16: Glucose Monitoring, Germany, Market Shares (%), 2008 33
Chart 17: Insulin Delivery, Germany, Market Shares (%), 2008 34
Chart 18: Diabetes Care Devices, Italy, Overall Sales ($ mn), from 2000 to 2015 35
Chart 19: Diabetes Care Devices, Italy, Cross-Category Analysis, from 2000 to 2015 36
Chart 20: Diabetes Care Devices, Italy, Overall Sales ($ mn), Historical data , from 2000 to 2008 37
Chart 21: Diabetes Care Devices, Italy, Overall Sales ($ mn), Forecasted data , from 2008 to 2015 38
Chart 22: Diabetes Care Devices, Italy, Segment Volume (Units), from 2000 to 2015 39
Chart 23: Diabetes Care Devices, Italy, Segment Volume (Units), Historical data , from 2000 to 2008 40
Chart 24: Diabetes Care Devices, Italy, Segment Volume (Units), Forecasted data , from 2008 to 2015 41
Chart 25: Diabetes Care Devices, Italy, Market Shares (%), 2008 43
Chart 26: Glucose Monitoring, Italy, Market Shares (%), 2008 44
Chart 27: Insulin Delivery, Italy, Market Shares (%), 2008 45
Chart 28: Diabetes Care Devices, France, Overall Sales ($ mn), from 2000 to 2015 46
Chart 29: Diabetes Care Devices, France, Overall Sales ($ mn), Historical data , from 2000 to 2008 47
Chart 30: Diabetes Care Devices, France, Overall Sales ($ mn), Forecasted data , from 2008 to 2015 48
Chart 31: Diabetes Care Devices, France, Segment Volume (Units), from 2000 to 2015 49
Chart 32: Diabetes Care Devices, France, Segment Volume (Units), Historical data , from 2000 to 2008 50
Chart 33: Diabetes Care Devices, France, Segment Volume (Units), Forecasted data , from 2008 to 2015 51
Chart 34: Diabetes Care Devices, France, Market Shares (%), 2008 53
Chart 35: Glucose Monitoring, France, Market Shares (%), 2008 54
Chart 36: Insulin Delivery, France, Market Shares (%), 2008 55
Chart 37: Diabetes Care Devices, United Kingdom, Overall Sales ($ mn), from 2000 to 2015 56
Chart 38: Diabetes Care Devices, United Kingdom, Overall Sales ($ mn), Historical data , from 2000 to 2008 57
Chart 39: Diabetes Care Devices, United Kingdom, Overall Sales ($ mn), Forecasted data , from 2008 to 2015 58
Chart 40: Diabetes Care Devices, United Kingdom, Segment Volume (Units), from 2000 to 2015 59
Chart 41: Diabetes Care Devices, United Kingdom, Segment Volume (Units), Historical data , from 2000 to 2008 60
Chart 42: Diabetes Care Devices, United Kingdom, Segment Volume (Units), Forecasted data , from 2008 to 2015 61
Chart 43: Diabetes Care Devices, United Kingdom, Market Shares (%), 2008 63
Chart 44: Glucose Monitoring, United Kingdom, Market Shares (%), 2008 64
Chart 45: Insulin Delivery, United Kingdom, Market Shares (%), 2008 65
Chart 46: Diabetes Care Devices, Spain, Overall Sales ($ mn), from 2000 to 2015 66
Chart 47: Diabetes Care Devices, Spain, Overall Sales ($ mn), Historical data , from 2000 to 2008 67
Chart 48: Diabetes Care Devices, Spain, Overall Sales ($ mn), Forecasted data , from 2008 to 2015 68
Chart 49: Diabetes Care Devices, Spain, Segment Volume (Units), from 2000 to 2015 69
Chart 50: Diabetes Care Devices, Spain, Segment Volume (Units), Historical data , from 2000 to 2008 70
Chart 51: Diabetes Care Devices, Spain, Segment Volume (Units), Forecasted data , from 2008 to 2015 71
Chart 52: Diabetes Care Devices, Spain, Market Shares (%), 2008 73
Chart 53: Glucose Monitoring, Spain, Market Shares (%), 2008 74
Chart 54: Insulin Delivery, Spain, Market Shares (%), 2008 75
Chart 55: Diabetes Care Devices, Netherlands, Overall Sales ($ mn), from 2000 to 2015 76
Chart 56: Diabetes Care Devices, Netherlands, Cross-Category Analysis, from 2000 to 2015 77
Chart 57: Diabetes Care Devices, Netherlands, Overall Sales ($ mn), Historical data , from 2000 to 2008 78
Chart 58: Diabetes Care Devices, Netherlands, Overall Sales ($ mn), Forecasted data , from 2008 to 2015 79
Chart 59: Diabetes Care Devices, Netherlands, Segment Volume (Units), from 2000 to 2015 80
Chart 60: Diabetes Care Devices, Netherlands, Segment Volume (Units), Historical data , from 2000 to 2008 81
Chart 61: Diabetes Care Devices, Netherlands, Segment Volume (Units), Forecasted data , from 2008 to 2015 82
Chart 62: Diabetes Care Devices, Netherlands, Market Shares (%), 2008 84
Chart 63: Glucose Monitoring, Netherlands, Market Shares (%), 2008 85
Chart 64: Insulin Delivery, Netherlands, Market Shares (%), 2008 86
Chart 65: Diabetes Care Devices, Belgium, Overall Sales ($ mn), from 2000 to 2015 87
Chart 66: Diabetes Care Devices, Belgium, Overall Sales ($ mn), Historical data , from 2000 to 2008 88
Chart 67: Diabetes Care Devices, Belgium, Overall Sales ($ mn), Forecasted data , from 2008 to 2015 89
Chart 68: Diabetes Care Devices, Belgium, Segment Volume (Units), from 2000 to 2015 90
Chart 69: Diabetes Care Devices, Belgium, Segment Volume (Units), Historical data , from 2000 to 2008 91
Chart 70: Diabetes Care Devices, Belgium, Segment Volume (Units), Forecasted data , from 2008 to 2015 92
Chart 71: Diabetes Care Devices, Belgium, Market Shares (%), 2008 94
Chart 72: Glucose Monitoring, Belgium, Market Shares (%), 2008 95
Chart 73: Insulin Delivery, Belgium, Market Shares (%), 2008 96
Chart 74: F. Hoffmann-La Roche Ltd Value Chain Analysis 98
Chart 75: Bayer HealthCare AG Value Chain Analysis 102
Chart 76: Abbott Laboratories Value Chain Analysis 108
Chart 77: Medtronic, Inc. Value Chain Analysis 113
Chart 78: Becton, Dickinson and Firms Value Chain Analysis 127
Chart 79: Eli Lilly and Firms Value Chain Analysis 129
Chart 80: Terumo Corporation Value Chain Analysis 133
Chart 81: Smiths Medical Value Chain Analysis 138
Chart 82: World March kets Direct Methodology 145

Talk to Robyn

00 1 718 213 49 04

Send Your Request

Follow

Add to circles Subscribe to our RSS feeds!

Pathology Industry in Germany : Latest Reports

Avandia (Type 2 Diabetes) - Analysis and Forecasts to 2020

$ 2 000
Company report
January 2012
by Global Data

Avandia (Type 2 Diabetes) - Analysis and Forecasts to 2020 Summary GlobalData's pharmaceuticals report, ?Avandia (Type 2 Diabetes) - Analysis and Forecasts to 2020? provides Avandia sales estimates fo ...

Janumet (Type 2 Diabetes) - Analysis and Forecasts to 2020

$ 2 000
Company report
January 2012
by Global Data

Janumet (Type 2 Diabetes) - Analysis and Forecasts to 2020 Summary GlobalData's pharmaceuticals report, ?Janumet (Type 2 Diabetes) - Analysis and Forecasts to 2020? provides Janumet sales estimates fo ...

Victoza (Type 2 Diabetes) - Analysis and Forecasts to 2020

$ 2 000
Company report
January 2012
by Global Data

Victoza (Type 2 Diabetes) - Analysis and Forecasts to 2020 Summary GlobalData's pharmaceuticals report, ?Victoza (Type 2 Diabetes) - Analysis and Forecasts to 2020? provides Victoza sales estimates fo ...

Basen (type 2 Diabetes) - Analysis And For ...

January 2012 $ 2 000

Januvia (type 2 Diabetes) - Analysis And F ...

January 2012 $ 2 000

Welchol (type 2 Diabetes) - Analysis And F ...

January 2012 $ 2 000

Bi 10773 (type 2 Diabetes) - Analysis And ...

January 2012 $ 2 000

Kombiglyze Xr (type 2 Diabetes) - Analysis ...

January 2012 $ 2 000

Ly2189265 (type 2 Diabetes) - Analysis An ...

January 2012 $ 2 000

Lantus (type 2 Diabetes) - Analysis And Fo ...

January 2012 $ 2 000

More Reports:

Pathology in Canada (48)

Pathology in France (204)

Pathology in Germany (210)

Pathology in Italy (206)

Pathology in Japan (263)

Pathology in Spain (206)

Pathology in the United Kingdom (198)

Pathology in the United States (482)

Company Reports

Black Box

Sanofi-Aventis Senegal

Amgen Inc.

Crucell N.V.

Cadila Healthcare Ltd.

Amarin Corporation PLC

Takeda Pharmaceutical Company Ltd.

GlaxoSmithKline P.L.C.

EpiCept Corp.

AstraZeneca PLC

Pathology Industry in Germany : Latest Downloads

Business Wire - Company Report for Year 2012

Company report
January 2012
12 pages

... And a cr rate of 8 percent. The overall safety profile was similar between the two arms. However, differences were observed in the inci- dence of peripheral neuropathy (pn). In the sub- cutaneous arm ...

Investor presentation: Pathology in China and The United States for Year 2011

Company report
November 2011
87 pages

... As a result of new information, future events or otherwise. Important drug information insulin degludec is an ultra-long acting basal insulin being developed. Degludec and degludecplus have been submitted ...

Company Report: Pathology for Year 2012

Company report
April 2012
4 pages

... Notable approval last year was victrelis, a major advance for the treatment of chronic hepatitis c. Compared to prior standard therapy alone, adding victrelis can significantly increase a patient ...